Cronos Group CRON Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Product | ||||||
| Cannabis extracts | $40.55M+34.9% | $37.7M+29.3% | $33.52M+48.4% | $31.35M+112% | $30.05M+271% | |
| Cannabis flower | $118.87M+26.8% | $108.48M+23.4% | $98.13M+19.6% | $98.1M+34.2% | $93.73M+41.0% | |
| Net revenue by Geography | ||||||
| Canada | $95.55M+14.2% | $90.33M+9.6% | $82.07M+1.7% | $83M+10.1% | $83.7M+21.1% | |
| Israel | $46.72M+49.8% | $41.8M+47.3% | $37.76M+47.9% | $33.67M+40.6% | $31.18M+38.6% | |
| Other countries | $17.27M+77.8% | $14.46M+112% | $12.53M+152% | $13.61M+459% | $9.71M+591% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cronos Group break its business down?
- Cronos Group (CRON) reports net revenue by product across 2 parts — Cannabis extracts and Cannabis flower. Each is extracted from the segment footnotes and tracked over time.
- Where does Cronos Group's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cronos Group's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
